GeneQuine to Present at Cell Therapy Manufacturing & Gene Therapy Congress (November 29 - 30, 2016, Amsterdam) [ 23 Nov 2016 ]

GeneQuine's CEO Kilian Guse will present at the Cell Therapy Manufacturing & Gene Therapy Congress on November 29. Dr. Guse will showcase GeneQuine's novel gene therapy platform and highlight data from the lead osteoarthritis development program.

The congress connects cell and gene therapy leaders to drive manufacturing and commercialisation through direct access to innovative discovery, product development and regulatory know-how.

Back